NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical studies when compared to traditional osteoconductive synthetic scaffolds.
NuVasive announced the launch of AttraX Putty and four other technologies earlier this quarter at the annual American Association of Neurological Surgeons meeting.
NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical...
NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical studies when compared to traditional osteoconductive synthetic scaffolds.
NuVasive announced the launch of AttraX Putty and four other technologies earlier this quarter at the annual American Association of Neurological Surgeons meeting.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
